Arkas Pharma Private Limited

Arkas Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2013PTC091634 Incorporated 12 December 2013 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Revenue · FY 2024
₹12.05 Cr
▲ 1% YoY
Net profit · FY 2024
₹81.31 Lakh
Net margin 6.8%
EBITDA · FY 2024
₹1.1 Cr
EBITDA margin 9.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Arkas Pharma Private Limited

Data last updated:

Arkas Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 December 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PTC091634. Its GSTIN is 36AAMCA2545D1ZV (Telangana).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors including Swapna Gorantla and Anil Kumar Gorantla.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No.1 – 4 – 180/80/A Sai Baba Officers Colony Sainikpuri Kapra, Hyderabad, Telangana, India – 500094.

As per the financials filed for FY 2024, the company reported a revenue of ₹12.05 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹81.31 Lakh (net margin 6.8%) and EBITDA of ₹1.1 Cr (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 16% over five years.

The company is associated with 1 brand: Arkas Pharma. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹39 Lakh; the latest was in March 2016. Its 6 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 3 smaller; the largest is Shilasagaram Enterprises Private Limited with revenue of ₹12.18 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arkaspharma.com.

Company details

CIN U24232TG2013PTC091634
Registration Number 091634
Incorporation Date 12 December 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Arkas Pharma has one previous CIN (Corporate Identification Number): U24232AP2013PTC091634. The current CIN is U24232TG2013PTC091634, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2013PTC091634Current
U24232AP2013PTC091634Previous

Contact details

Arkas Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is arkaspharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    H.No.1 – 4 – 180/80/A Sai Baba Officers Colony Sainikpuri Kapra, Hyderabad, Telangana, India – 500094
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Arkas Pharma Private Limited, buy the company report.

Comprehensive company report
Arkas Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Arkas Pharma operates one associated brand: Arkas Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing and services focusing on medicines for cardiology, diabetes, and other categories in India.arkaspharma.com

Business activity

The main business activity of Arkas Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Arkas Pharma Private Limited, buy the company report.

Financials of Arkas Pharma Private Limited

FY 2024 filings available

Arkas Pharma Private Limited reported revenue of ₹12.05 Cr (up 1% YoY) for FY 2024.

Revenue · FY 2024
₹12.05 Cr ▲ 1%
Net profit · FY 2024
₹81.31 Lakh margin 6.8%
EBITDA · FY 2024
₹1.1 Cr margin 9.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 12%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 11%
5 years · compounded
▲ 21%

Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 1% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.1 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹81.31 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin9.1%
Net Profit Margin6.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Arkas Pharma Private Limited, buy the company report.

Board of directors of Arkas Pharma Private Limited

Arkas Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Swapna GorantlaDirector12 Dec 201312 Years 11 MonthsCurrent
Anil Kumar GorantlaDirector15 Nov 201412 Years 0 MonthsCurrent
Raja ShekarDirector11 Jun 20206 Years 5 MonthsCurrent

Peer comparison

Arkas Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Shilasagaram Enterprises Private Limited₹12.18 Cr (FY 2024)-9.0%Hyderabad, Telangana, India
Slava Therapeutics Private Limited₹12.14 Cr (FY 2020)138.0%Hyderabad, Telangana, India
Nandan Pharma Private Limited₹12.12 Cr (FY 2024)8.0%Thane, Maharashtra, India
Arkas Pharma Private Limitedthis company₹12.05 Cr (FY 2024)₹81.31 Lakh6.8%1.0%Hyderabad, Telangana, India
Originix Healthcare Private Limited₹12.03 Cr (FY 2020)-17.0%Hyderabad, Telangana, India
Eyeskape Medicals Private Limited₹12.03 Cr (FY 2024)-5.0%Mumbai, Maharashtra, India
Trivio Healthcare Private Limited₹12.03 Cr (FY 2025)64.0%Gujarat, India

To see the full peer comparison of Arkas Pharma Private Limited, buy the company report.

Auditor

Arkas Pharma Private Limited is audited by THIRUPATHI & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
THIRUPATHI & ASSOCIATESFY 2020013000S

Shareholding

The shareholding of Arkas Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Arkas Pharma Private Limited, buy the company report.

Deals & funding

Arkas Pharma Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹39 Lakh; the latest was in March 2016.

Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹39 Lakh

Deals on record (3 of 3)

WhenDealAmountParties
Mar 2016Funding round₹39 LakhInvestors: 4 individuals
Jul 2014Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals
Dec 2013Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Arkas Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Arkas Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAMCA2545D1ZVTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Arkas Pharma Private Limited, buy the company report.

Recent activity

Arkas Pharma Private Limited has 9 board changes on record since 2013: 3 appointments and 6 cessations. The latest: Muppiri Shetty Santosh Kumar ceased to be Director on 02 Oct 2023.

AGM
Arkas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Arkas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Muppiri Shetty Santosh Kumar ceased to be Director.
Appointed
Raja Shekar was appointed as Director.
Ceased
Anil Kumar Gorantla ceased to be Additional Director.
Ceased
Mavilla Beenarani ceased to be Director.
Appointed
Anil Kumar Gorantla was appointed as Director.
Ceased
Ruchira Deb ceased to be Director.
Ceased
Unnati Kirti Modi ceased to be Director.
Ceased
Sriram Sridevi ceased to be Director.
Appointed
Swapna Gorantla was appointed as Director.
Incorporation
12 Dec 2013
Arkas Pharma Private Limited was registered on 12 Dec 2013 with Roc Hyderabad & aged 12 years 11 months as per MCA records.

Frequently asked questions

Arkas Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 December 2013 (13+ years old) and is registered under CIN U24232TG2013PTC091634.

Arkas Pharma has 3 current directors:

The latest financial statements of Arkas Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Arkas Pharma is 36AAMCA2545D1ZV, registered in Telangana.

The CIN (Corporate Identification Number) of Arkas Pharma is U24232TG2013PTC091634. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Arkas Pharma was incorporated on 12 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.

Arkas Pharma has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹39 Lakh; the latest was in March 2016.

The peers of Arkas Pharma by revenue are Shilasagaram Enterprises Private Limited, Slava Therapeutics Private Limited, Nandan Pharma Private Limited, Originix Healthcare Private Limited, Eyeskape Medicals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Muppiri Shetty Santosh Kumar ceased to be Director on 02 Oct 2023. Raja Shekar was appointed as Director on 11 Jun 2020. Anil Kumar Gorantla ceased to be Additional Director on 29 Sep 2015. Arkas Pharma has 9 board changes on record in total.

Arkas Pharma can be reached through the website arkaspharma.com. Its registered office is in Hyderabad, Telangana, India.

The registered office of Arkas Pharma is at H.No.1 – 4 – 18080A Sai Baba Officers Colony Sainikpuri Kapra, Hyderabad, Telangana, India – 500094.